These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26219379)

  • 1. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation.
    Melis D; Rossi A; Pivonello R; Salerno M; Balivo F; Spadarella S; Muscogiuri G; Casa RD; Formisano P; Andria G; Colao A; Parenti G
    Orphanet J Rare Dis; 2015 Jul; 10():91. PubMed ID: 26219379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement.
    Rossi A; Simeoli C; Salerno M; Ferrigno R; Della Casa R; Colao A; Strisciuglio P; Parenti G; Pivonello R; Melis D
    Orphanet J Rare Dis; 2020 Apr; 15(1):99. PubMed ID: 32306986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?
    Rossi A; Ruoppolo M; Formisano P; Villani G; Albano L; Gallo G; Crisci D; Moccia A; Parenti G; Strisciuglio P; Melis D
    J Inherit Metab Dis; 2018 Nov; 41(6):985-995. PubMed ID: 29435782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphatase deficiency.
    Froissart R; Piraud M; Boudjemline AM; Vianey-Saban C; Petit F; Hubert-Buron A; Eberschweiler PT; Gajdos V; Labrune P
    Orphanet J Rare Dis; 2011 May; 6():27. PubMed ID: 21599942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Hornemann T; Alecu I; Hagenbuch N; Zhakupova A; Cremonesi A; Gautschi M; Jung HH; Meienberg F; Bilz S; Christ E; Baumgartner MR; Hochuli M
    Mol Genet Metab; 2018 Sep; 125(1-2):73-78. PubMed ID: 30037504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
    Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
    J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.
    Kaiser N; Gautschi M; Bosanska L; Meienberg F; Baumgartner MR; Spinas GA; Hochuli M
    Mol Genet Metab; 2019 Apr; 126(4):355-361. PubMed ID: 30846352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver microsomal transport of glucose-6-phosphate, glucose, and phosphate in type 1 glycogen storage disease.
    Marcolongo P; Bánhegyi G; Benedetti A; Hinds CJ; Burchell A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):224-9. PubMed ID: 9435446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The signature motif in human glucose-6-phosphate transporter is essential for microsomal transport of glucose-6-phosphate.
    Pan CJ; Chen LY; Mansfield BC; Salani B; Varesio L; Chou JY
    Hum Genet; 2003 Apr; 112(4):430-3. PubMed ID: 12560945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I.
    Mathis T; Poms M; Köfeler H; Gautschi M; Plecko B; Baumgartner MR; Hochuli M
    J Inherit Metab Dis; 2022 Mar; 45(2):235-247. PubMed ID: 34671989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type Ib.
    Chen SY; Pan CJ; Lee S; Peng W; Chou JY
    Mol Genet Metab; 2008 Dec; 95(4):220-3. PubMed ID: 18835800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of fructose-6-phosphate to glucocorticoid activation in the endoplasmic reticulum: possible implication in the metabolic syndrome.
    Senesi S; Legeza B; Balázs Z; Csala M; Marcolongo P; Kereszturi E; Szelényi P; Egger C; Fulceri R; Mandl J; Giunti R; Odermatt A; Bánhegyi G; Benedetti A
    Endocrinology; 2010 Oct; 151(10):4830-9. PubMed ID: 20826560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders.
    Maiorana A; Tagliaferri F; Dionisi-Vici C
    Front Endocrinol (Lausanne); 2023; 14():1145111. PubMed ID: 37152929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose 6-phosphate transport in fibroblast microsomes from glycogen storage disease type 1b patients: evidence for multiple glucose 6-phosphate transport systems.
    Leuzzi R; Fulceri R; Marcolongo P; Bánhegyi G; Zammarchi E; Stafford K; Burchell A; Benedetti A
    Biochem J; 2001 Jul; 357(Pt 2):557-62. PubMed ID: 11439108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia.
    Haring MPD; Peeks F; Oosterveer MH; Brouwers MCGJ; Hollak CEM; Janssen MCH; Langendonk JG; Rennings AJM; Wagenmakers MAEM; Verkade HJ; Derks TGJ; de Meijer VE
    JHEP Rep; 2022 Aug; 4(8):100512. PubMed ID: 35811762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].
    Qiu ZQ; Lu CX; Wang W; Qiu JJ; Wei M
    Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):203-8. PubMed ID: 21575371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
    Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
    FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene mutations and clinical manifestations in children with glycogen storage disease type Ib].
    Liang CL; Liu L; Sheng HY; Jiang MY; Yin X; Mei HF; Cheng J; Zhang W; Fan LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):661-5. PubMed ID: 23965881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.